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The spectrum of tasks which is fulfilled by CD4 T cells in the setting of viral infections
is large, ranging from support of CD8 T cells and humoral immunity to exertion of direct
antiviral effector functions. While our knowledge about the differentiation pathways, plas-
ticity, and memory of CD4 T cell responses upon acute infections or immunizations has
significantly increased during the past years, much less is still known about CD4 T cell dif-
ferentiation and their beneficial or pathological functions during persistent viral infections.
In this review we summarize current knowledge about the differentiation, direct or indirect
antiviral effector functions, and the regulation of virus-specific CD4 T cells in the setting
of persistent latent or active chronic viral infections with a particular emphasis on herpes
virus infections for the former and chronic lymphocytic choriomeningitis virus infection for
the latter.
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CD4 T CELL RESPONSES DURING LATENT PERSISTENT VIRAL
INFECTION
INTRODUCTION
Many viral infections are controlled by the host’s CD8 and B
cell responses, leading to clearance of the infecting pathogen
(acute/resolved infections). In this context CD4 T cells were mainly
implicated to support CD8 T cell responses, especially during sec-
ondary infections, as well as in supporting B cells through their
support of antibody class switch recombination and affinity mat-
uration. However, in chronic latent infections as established by
herpes viruses, CD4 T cells not only support CD8 T cells and B
cells but exert direct antiviral effector functions that are crucial for
terminating lytic replication and establishing viral latency, for con-
trolling viral reactivation events, and finally to prevent morbidity
and mortality of the host. Due to the generally low frequency of
virus-specific CD4 T cells, this cell subset is far more difficult to
study than their CD8 counterpart. Major advances in the study of
chronic latent infections in recent years, however, unraveled not
only the importance but also the phenotype and the functional
capabilities of this T cell population. In the next paragraphs we
will review the functions and phenotypes of CD4 T cells generated
during chronic latent herpes virus infections with a special focus
on Cytomegalovirus (CMV) (Figure 1A).
ROLE OF CD4 T CELLS IN LATENT PERSISTENT VIRAL INFECTIONS
Human studies of primary immune deficiencies strongly indicate
that CD4 T cells may be even more important than CD8 T cells
in the control of herpes virus infections (Carneiro-Sampaio and
Coutinho, 2007) (summarized in Table 1). In contrast to patients
with compromised CD8 T cell functions, the susceptibility to viral
infections, especially infections with the herpes virus family, was
increased in patients with CD4 T cell deficiencies. The notion that
robust CD4 T cell responses are beneficial for control of herpes
virus infections is further supported by studies of chronically HIV
infected individuals. HIV patients often suffer from herpes virus
related disease due to frequent and uncontrolled viral reactivation.
Patients with CD4 T cell counts below 100 cells/µl are at high risk
to develop CMV-related disease (Gallant et al., 1992; Cinque et al.,
1998) and CMV-seropositive HIV patients progress significantly
faster to AIDS than their CMV negative counterparts (Webster
et al., 1989; Sabin et al., 1995). Similarly, primary CMV infection in
HIV patients, even with CD4 T cell counts>100 cells/µl, correlates
with increased risk for earlier onset of AIDS (Robain et al., 2001).
In a study of HIV-1-infected individuals loss of HCMV-specific
CD4 T cells preceded CMV end-organ disease (Komanduri et al.,
1998). Even in two patients with CD4 T cell counts above 400
cells/µl, recurrent CMV-related retinitis correlated with the loss
of HCMV-specific CD4 T cells (Komanduri et al., 2001b). More
recently, a correlation between low CD4 T cell counts and Kaposi
sarcoma herpes virus (KSHV) DNA viremia was demonstrated
in HIV infected individuals (Parisi et al., 2011). Low numbers of
CD4 T cells in immune suppressed patients is further a risk factor
for the development of EBV related disease (Sebelin-Wulf et al.,
2007).
The reconstitution of T cell immunity through infusion of
ex vivo expanded virus-specific T cells in solid organ transplant
patients undergoing herpes virus reactivation further confirmed
the protective role of CD4 T cells. Adoptive transfer of VZV-
specific T cells in hematopoietic cell transplant recipients undergo-
ing VZV reactivation led to reconstitution of VZV-specific CD4 T
cell responses and correlated with a reduced risk of VZV-induced
disease (Hata et al., 2002; Blyth et al., 2012). Infusion of CMV-
specific T cell lines restored HCMV-specific CD4 T cell immunity
in stem cell transplant patients with CMV viremia which also cor-
related with reduced virus load (Einsele et al., 2002). Similarly,
the presence of CMV-specific CD4 T cells correlated with virus
control in renal or lung transplant patients (Gamadia et al., 2004;
Akulian et al., 2013).
In renal transplant patients, early emergence of HCMV-specific
CD4 T cells was an indicator for viral control (Gamadia et al.,
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FIGURE 1 | CD4T cell function, differentiation, and regulation during
persistent viral infections. (A) Latent persistent viral infections. In the left
panel aspects of CD4 T cell immune responses with specificity for antigens of
latent persistent viral infections are summarized: direct antiviral effector
functions (discussed in paragraph Direct Antiviral Effector Functions of CD4 T
Cells in Latent Persistent Viral Infections), support of CD8 T cell responses
(CD4 T Cells Support Virus-Specific CD8 T Cells During Latent Persistent Viral
Infections), support of B cell responses (CD4 T Cells Support Humoral
Responses During Latent Persistent Viral Infections), immune regulation
(Regulatory CD4 T Cells in Latent Persistent Viral Infections), and
immunopathology (Role of CD4 T Cells in Latent Persistent Viral Infections and
IL-10 Producing CD4 T Regulatory Cells). In the right panel viral strategies
leading to escape from CD4 T cell responses are summarized (discussed in
paragraph Viral Escape from CD4 T Cells). (B) Chronic active viral infections. In
the left panel aspects of CD4 T cell immune responses with specificity for
antigens of chronic viral infections are summarized: direct antiviral effector
functions (discussed in paragraph CD4 T Cells Promoting Control of Chronic
Viral Infection), support of CD8 T cell responses (CD4 T Cells Promoting
Control of Chronic Viral Infections), support of B cell responses (Differentiation
of CD4 T Cells During Active Chronic Viral Infections), immune regulation (Tregs
and Chronic Viral Infections), and immunopathology (CD4 T Cell Mediated
Pathology During Chronic Viral Infections). In the right panel viral strategies
leading to escape from CD4 T cell responses are summarized (discussed in
paragraphs CD4 T Cells Promoting Control of Chronic Viral Infection,
Differentiation of CD4 T Cells During Active Chronic Viral Infections, and Tregs
and Chronic Viral Infections).
2003; Tormo et al., 2011). In this study, a robust virus-specific
CD4 T cell response preceded the CD8 T cell response in asymp-
tomatic patients but not in patients suffering from HCMV-related
disease. Further, as discussed in more detail in a later section,
CD4 T cells were suggested to be important for the maintenance
of functional antiviral CD8 T cells in several studies of trans-
plant recipients (Walter et al., 1995; Einsele et al., 2002). Data
from patients with post-transplant lymphoproliferative disorder
(PTLD) indicate that transfer of EBV-specific CD4 T cells has a
beneficial effect (Haque et al., 2007). These data are supported by
murine models where CD4 T cells are efficient to control PTLD-
like and Burkitt’s lymphoma even in the absence of CD8 T cells
(Fu et al., 2004; Merlo et al., 2010).
Evidence that CD4 T cells are crucial antiviral effector cells
in the control of herpes virus infections not only come from
immunosuppressed patients but also from healthy individuals.
Primary infection in children is accompanied with prolonged
shedding of virus in the urine which was found to correlate
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Table 1 | Role of CD4T cells in herpes viral infections.
Viral
infection
Role of CD4T cells
Establishment of viral
latency/control of lytic
viral replication
Maintenance of
latency/inhibition of
viral recrudescence
Immunopathology/
immune
senescence
Protective role in
immunotherapy or
immunization
HSV Primary immunodeficiency
(Carneiro-Sampaio and Coutinho, 2007);
vaginal tract, sensory ganglia in mice
(Milligan and Bernstein, 1997; Gill and
Ashkar, 2009)
Immunopathology
(Hendricks and Tumpey,
1990; Hendricks et al.,
1992)
Protective role in vaccine
models (Milligan et al., 1998;
BenMohamed et al., 2003);
major mediator of immunity
in cornea (Hendricks and
Tumpey, 1990; Hendricks
et al., 1992)
VZV Primary immunodeficiency
(Carneiro-Sampaio and Coutinho, 2007);
inverse correlation between viremia and
virus-specific CD4 T cell response
(Abendroth and Arvin, 2001; Malavige
et al., 2008); SVV: (VZV infection model in
rhesus macaques) prolonged viremia and
higher viral titers in CD4 T cell depleted
animals (Haberthur et al., 2011)
Positive correlation between
CD4 T cell immunity and
protection in the aged (Levin and
Hayward, 1996; Weinberg et al.,
2009) and in hematopoietic cell
transplant recipients (Hata et al.,
2002); increased reactivation in
HIV carriers (Buchbinder et al.,
1992)
Tonsillar CD4 T cells
carry virus from the LN
to the skin (Ku et al.,
2002, 2004)
Protective role in transplant
recipients with antiviral
adoptive transfer treatment
(Hata et al., 2002; Blyth et al.,
2012)
MCMV Particularly at mucosal sites (salivary
glands) (Jonjic et al., 1989, 1990; Walton
et al., 2011a)
Polic et al. (1998) CD4 T cells isolated from CD8
deficient mice (Jonjic et al.,
1990)
HCMV Primary immunodeficiency
(Carneiro-Sampaio and Coutinho, 2007);
inverse correlation between viremia and
virus-specific CD4 T cell response (young
children versus adults) (Tu et al., 2004)
Reactivation in HIV patients with
low CD4 T cell counts (Gallant
et al., 1992; Cinque et al., 1998);
loss of CMV-specific CD4 T cells
(Komanduri et al., 1998, 2001b)
Graft-versus-host
disease (Cray and Levy,
1993); myocarditis
(Lenzo et al., 2002),
atherosclerosis (Sacre
et al., 2012), immune
senescence (Karrer
et al., 2009)
Transplant recipients (Einsele
et al., 2002; Gamadia et al.,
2003, 2004; Tormo et al.,
2011; Akulian et al., 2013),
septic shock patients (von
Muller et al., 2007)
MHV-68 Particularly at mucosal sites (lung)
(Christensen et al., 1999; Sparks-Thissen
et al., 2005)
Cardin et al. (1996) Adoptive transfer
(Sparks-Thissen et al., 2005);
immunization (Liu et al., 1999)
EBV Primary immunodeficiency
(Carneiro-Sampaio and Coutinho, 2007)
Reactivation in
immunosuppressed patients
with low CD4 T cell counts
(Sebelin-Wulf et al., 2007)
Implicated in sustaining
primary infection
(Veronese et al., 1992;
Fu and Cannon, 2000;
Johannessen et al.,
2000; Wagar et al.,
2000; MacArthur et al.,
2007)
Protective role in PTLD
disorders following adoptive
transfer of virus-specific CD4
T cells (Haque et al., 2007);
murine model of PTLD-like
and Burkitt’s lymphoma (Fu
et al., 2004; Merlo et al., 2010)
with impaired induction of CMV-specific CD4 T cells but sim-
ilar CD8 T cell responses compared to adults (Tu et al., 2004).
In septic shock patients with an otherwise competent immune
system, CMV recurrence was accompanied with an increase of
HCMV-specific CD4 T cells and suppression of CMV replica-
tion was attributed to this T cell compartment (von Muller
et al., 2007). Unfortunately, as HCMV-specific CD8 T cell
responses were not analyzed concomitantly, the protective roles
exerted by CD4 versus CD8 T cells remain elusive in these
patients.
Findings in human studies of herpes virus infection correlate
closely with data from mouse models. Although the acute phase
of herpes virus infection can be controlled by redundant immune
cell subsets involving CD8 T cells, B cell, and NK cells, CD4 T cells
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seem to have a crucial role in the establishment of viral latency
and in the long-term control of the infection. For example, during
MCMV infection, lytic viral replication cannot be controlled in
the salivary glands in the absence of CD4 T cells and increased
viral titers or prolonged viral replication can be detected in the
spleen, lung, and liver (Jonjic et al., 1989, 1990). Further, CD4 T
cells, in interplay with other immune cells, prevent viral recrude-
scence (Polic et al., 1998). In B cell-deficient mice direct antiviral
effector mechanisms exerted by CD4 T cells were shown to be
equally important to CD8 T cells for control of acute murine
herpes virus (MHV)-68 replication (Christensen et al., 1999).
Further, CD4 T cells are also essential for the control of HSV-2
replication at the site of infection, i.e., the vaginal tract (Milli-
gan et al., 1998; Nakanishi et al., 2009), and in HSV-1 infection
CD4 T cells are thought to be the major mediator of immunity
in the cornea, but simultaneously may also be a major inducer
of immunopathology (Hendricks and Tumpey, 1990; Hendricks
et al., 1992).
The notion that CD4 T cells not only have a beneficial role was
reported also for other herpes virus infections apart from HSV.
The CD4 T cell subset may have deleterious effects in exacerbating
collateral diseases such as myocarditis, immune senescence as well
as graft-versus-host disease in CMV-seropositive patients (Cray
and Levy, 1993; Lenzo et al., 2002; Karrer et al., 2009), and in
EBV infection CD4 T cells, especially with a Th2 phenotype, may
sustain primary infection via the expansion of EBV-transformed
B cells (Veronese et al., 1992; Fu and Cannon, 2000; Johannessen
et al., 2000; Wagar et al., 2000; MacArthur et al., 2007).
Direct antiviral effector functions of CD4 T cells in latent persistent
viral infections
Although CD4 T cells were shown to have direct effector func-
tion in some acute resolved infections (Maloy et al., 2000; Brown
et al., 2006, 2012), CD4 T cells are mainly thought to orchestrate
other immune cells which then eradicate the infecting pathogens
(summarized in Table 2). Their ability to produce a wide range of
cytokines as well as their expression of various cell surface mol-
ecules implied in regulating immune functions (e.g., CD40L) in
response – and importantly – adapted to different stimuli, endows
them with the ability to modulate the immune response in a
way that the most effective elimination of the causative agent is
promoted. However, it becomes more and more apparent that
although helper mechanisms are indeed a major function of CD4
T cells, this cell subset is also able to kill or inhibit pathogen replica-
tion in a more direct way during herpes virus infections (Stevenson
et al., 2009). In recent years great advances were made to dissect
exact antiviral mechanisms exerted by CD4 T cells during herpes
virus infections, especially by using mouse models.
IFNγ. The observation that MCMV-specific CD4 T cells might
directly protect the host via secretion of IFNγ was first reported by
Lucin et al. (1992) as IFNγ neutralization and CD4 T cell depletion
led to a comparable increase in viral titers in the salivary glands.
In adoptive transfer studies, CD4 T cells isolated from MCMV-
infected CD8 T cell-deficient mice dramatically decreased viral
titers in sublethally γ-irradiated hosts in an IFNγ dependent man-
ner (Jonjic et al., 1990; Polic et al., 1996). Although transfer of
immune CD4 T cells was necessary for the observed protection,
they were not sufficient, suggesting that CD4 T cells have to inter-
play with another cell type to confer protection. From this studies
it was postulated that CD4 T cells cross-talk via IFNγ with other
immune cells (e.g., NK cells in the salivary glands) to accomplish
viral protection (Campbell et al., 2008). This hypothesis was chal-
lenged by recent results from our laboratory (Walton et al., 2011a).
Using mixed bone marrow chimeras, we were able to verify that
IFNγ secreted by CD4 T cells indeed directly controls MCMV
replication in the salivary glands. IFNγ receptor (IFNγR) expres-
sion on irradiation resistant cells but not on immune cells was
required for the control of viral replication, suggesting that IFNγ
secreted by CD4 T cell signals either directly on infected non-
hematopoietic cells or on bystander non-immune cells to confer
protection and is not required for activation of other immune cells.
The importance of IFNγ-secreting CD4 T cells in CMV was fur-
ther supported by clinical data as higher levels of IFNγ-producing
CD4 T cells correlated with faster viral control and reduced clinical
symptoms (Sester et al., 2001; Gamadia et al., 2003; Nebbia et al.,
2008).
The crucial role of IFNγ produced by CD4 T cells to inhibit her-
pes virus replication was also confirmed in the context of MHV-68
infection (Sparks-Thissen et al., 2005): IFNγ seems to act directly
on myeloid cells where it suppresses viral lytic gene expression
(Steed et al., 2007). However, the role of IFNγ in the control of
latency is more controversial and likely strain dependent (Dutia
et al., 1997; Sarawar et al., 1997; Tsai et al., 2011). In HSV-2 infec-
tion IFNγ-producing CD4 T cells seem to be essential to establish
latent infection (Chan et al., 2011).
TNF. As treatment of MCMV-infected mice with recombinant
IFNγ could not substitute for the lack of CD4 T cells, it was believed
that CD4 T cells act via an additional mechanism to control viral
replication. TNF was the most likely candidate due to the fact
that IFNγ synergistically acts in vitro with TNF to inhibit viral
replication (van der Meer et al., 1989; Pavic et al., 1993; Lucin
et al., 1994). However, concomitant administration of recombi-
nant IFNγ and TNF did not lead to the anticipated effect of
enhanced viral control in the salivary glands in the absence of
CD4 T cells (Pavic et al., 1993). In vivo administration of anti-
TNF antibodies increased viral load in the salivary glands which
led to the interpretation that neutralization of TNF abolishes the
antiviral activities of CD4 T cells. However, in contrast to this
hypothesis, when only CD4 T cells were deficient in TNF secre-
tion, viral control in the salivary gland was comparable to wild
type animals (Walton et al., 2011a). This demonstrates that CD4
T cells do not have to secrete TNF by themselves to cease MCMV
replication in the salivary glands, but does not exclude that TNF
secreted by other cells is crucial to confer protection in the salivary
glands.
Cytotoxicity. Cytotoxic CD4 T cells during herpes virus infec-
tions were mainly studied in humans for a wide range of herpes
viruses including HCMV, EBV, and VZV (Martorelli et al., 2010;
Weinberg and Levin, 2010). Following primary HCMV infection
a subpopulation of CD4 T cells emerges that is CD28 negative,
expresses granzyme B, and maybe possesses cytotoxic capacities
Frontiers in Immunology | Immunological Memory May 2013 | Volume 4 | Article 105 | 4
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Table 2 | CD4T cell effector functions in herpes viral infections.
Viral
infection
CD4T cell effector function
Direct antiviral effector
function of CD4T cells
Support of CD8T cell responses Support of humoral responses
HSV IFNγ (Chan et al., 2011) Support of immigration into infected tissue
via IFNγ-dependent mechanism (Nakanishi
et al., 2009); support entry into draining
lymph node (Kumamoto et al., 2011); priming
of CD8 T cells and function (IFNγ and TNF
secretion but not cytotoxicity) (Jennings
et al., 1991; Rajasagi et al., 2009)
Antibodies mediate limited control (Chan
et al., 2011)
VZV Support CD8 T cells in SVV infected animals
(Haberthur et al., 2011)
Protective role of passively transferred
antibodies (Gershon et al., 1974; Zaia et al.,
1983); support of isotype-switched
antibodies in SVV infected animals
(Haberthur et al., 2011)
MCMV IFNγ (Jonjic et al., 1990; Lucin et al., 1992;
Polic et al., 1996; Walton et al., 2011a)
Memory inflation and maintenance of
functionality (Snyder et al., 2009; Walton
et al., 2011b); help likely provided by IL-2
secretion (Walton et al., 2011b)
Support of isotype-switched antibodies
(Jonjic et al., 1989); antibodies inhibit viral
dissemination during acute viral replication
and reactivation (Jonjic et al., 1994; Polic
et al., 1998; Klenovsek et al., 2007; Wirtz
et al., 2008)
HCMV IFNγ (Sester et al., 2001; Gamadia et al.,
2003; Nebbia et al., 2008); cytotoxicity
(Tazume et al., 2004; van Leeuwen et al.,
2004, 2006; Casazza et al., 2006; Delmas
et al., 2007; van de Berg et al., 2008)
In transplant recipients (Walter et al., 1995;
Einsele et al., 2002); in HIV patients
(Komanduri et al., 2001a)
Administration of HCMV antibodies is
beneficial in some cases (Yeager et al., 1981;
Snydman et al., 1987; Fowler et al., 1992;
Guglielmo et al., 1994; Messori et al., 1994;
Harrison et al., 1995; Munoz et al., 2001)
MHV-68 IFNγ (Dutia et al., 1997; Sarawar et al.,
1997; Sparks-Thissen et al., 2005; Tsai
et al., 2011)
Progressive loss of virus-specific CD8 T cells
in absence of CD4 T cell (Cardin et al., 1996);
increased suppressive IL-10-producing and
PD-1+ CD8 T cells in absence of CD4 T cells
(Dias et al., 2010; Molloy et al., 2011)
Protective role of antibodies in lytic viral
replication (Wright et al., 2009) and in
recrudescence (Gangappa et al., 2002; Kim
et al., 2002)
EBV Soluble factors (Nagy et al., 2012);
cytotoxicity (Khanolkar et al., 2001; Sun
et al., 2002; MacArthur et al., 2007; Haigh
et al., 2008)
B cell deficiency lack of viral persistence but
also reservoir (Faulkner et al., 2000)
in renal transplant recipients (van Leeuwen et al., 2004). HCMV-
specific CD4 T cells specific for pp65 showed surface mobilization
of CD107a, a marker for degranulation, with concurrent loss of
granzyme in response to in vitro restimulation (Casazza et al.,
2006). Further, in the same studies, expression of granzyme A
and B as well as perforin was highly elevated in terminally dif-
ferentiated CD27−, CD57+ memory CD4 T cells, implicating
that HCMV-specific CD4 T cells gain cytotoxic capacities with
their increased maturation status. This attributed potential of
cytotoxic activity of HCMV-specific CD4 T cells was verified by
in vitro killing assays with antigen-pulsed EBV-transformed B
lymphoblastoid cells (B-LCLs) incubated with CD4 T cells iso-
lated directly ex vivo (Casazza et al., 2006; van Leeuwen et al.,
2006). Using polyclonal CMV-specific CD4 T cell lines, Tazume
et al. were able to demonstrate that these cells are able to kill
HCMV-infected fibroblasts via a perforin-dependent mechanism
as well as via Fas–FasL interaction. Further, direct cytolytic func-
tions toward CMV-infected fibroblasts were dependent of IFNγ-
induced upregulation of HLA-DR and required a 16 h incubation
period (Tazume et al., 2004). These findings were challenged by a
more recent study using IE1-specific CD4 T cell clones claiming
that these cells are able to kill peptide-pulsed but not HCMV-
infected target cells; although degranulation of CD4 T cells was
measured after incubation with either target cells (Delmas et al.,
2007). However, discrepancies in the incubation time of 16 ver-
sus 5 h could possibly explain this discrepancy. In accordance with
the latter study, Tovar-Salazar et al. (2009) propose that HCMV-
specific CD4 T cells fulfill a regulatory rather than cytotoxic
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functions. CD27− CD28− CD4 T cells sorted from HCMV-
stimulated PBMCs of CMV-seropositive donors inhibited prolif-
eration of autologous CMV-specific T cells in a dose-dependent
manner, at least partly via secretion of TGFβ and granzyme B.
Studies addressing cytotoxic CD4 T cells in the mouse model are
very sparse (Jellison et al., 2005; Brown et al., 2006). However
in mixed bone marrow chimeras that lacked perforin expression
exclusively in CD4 T cells, MCMV replication was controlled in
the salivary gland and in other organs comparably to their wild
type counterparts (Walton et al., 2011a). This argues against a
major role for cytotoxic CD4 T cells in MCMV infection; although
cytolytic function via Fas–FasL interaction has not been addressed
so far.
Granzyme, perforin, and granulysin expressing EBV-specific
CD4 T cells were also documented in vivo and in vitro (Sun et al.,
2002; MacArthur et al., 2007). In vitro, EBV-specific CD4 T cell
clones exhibited cytolytic functions as assessed by the release of
cytotoxic granules (Khanolkar et al., 2001; Sun et al., 2002) and to
a lesser extent by Fas/FasL induced cell death (Wilson et al., 1998).
Further, EBV CD4 T cell cultures expressing cytotoxic effector
molecules (e.g., expression of granzymes, perforin, granulysins)
inhibited long-term LCL growth (Haigh et al., 2008). Thus, CD4
T cells with cytolytic functions seem to be a hallmark of herpes
virus infections.
CD4 T cells support virus-specific CD8 T cells during latent
persistent viral infections
A role of CD4 T cells in providing help to CD8 T cells during CMV
infection was already proposed a decade ago by studies carried out
in HIV-1-infected patients (summarized in Table 2). In these indi-
viduals a strong HCMV-directed CD4 T cell response correlated
with increased frequencies of HCMV-specific CD8 T cells recog-
nizing an epitope of the pp65 ORF (Komanduri et al., 2001a).
In human bone marrow transplant recipients, virus-specific CD8
T cells were able to protect from HCMV-related disease, how-
ever, their long-term maintenance depended on the presence of
HCMV-specific CD4 T cells (Walter et al., 1995; Einsele et al.,
2002).
More recently, the impact of CD4 T cell help on CD8 T cell
responses was addressed in the context of MCMV infection by our
group (Walton et al., 2011b) and others (Snyder et al., 2009). Lack
of CD4 T cells impaired MCMV-specific CD8 T cell inflation [i.e.,
a continued accumulation of CMV-specific CD8 T cells over the
course of CMV latency (Torti and Oxenius, 2012)], the mainte-
nance of the memory CD8 T cell pool for the non-inflationary
M45 and M57 epitopes, and the functionality of MCMV-specific
CD8 T cells. MCMV-specific CD8 T cells isolated from a CD4 T
cell-deficient environment displayed a more activated phenotype,
indicating more frequent reencounter with their cognate antigens
in the context of CD4 T cell deficiency. These observed differ-
ences were interpreted by Snyder et al. (2009) to be caused by the
increased antigen burden seen in CD4 T cell-deficient MCMV-
infected mice. However, when MCMV replication was controlled
by interventional measures, it was revealed that in concomitant
absence of ongoing replication and CD4 T cell help, MCMV-
specific CD8 T cell inflation was completely abrogated. These
data demonstrate that during MCMV infection (i) CD4 T cells
are crucial for memory inflation of virus-specific CD8 T cells
in the absence of overt viral replication, (ii) CD4 T cells sup-
port MCMV-specific CD8 T cells to remain functional, and (iii)
long-term maintenance of non-inflationary MCMV-specific CD8
T cells is dependent on CD4 T cells.
Findings that CD4 T cells crucially influence MCMV-specific
CD8 T cell responses were further underlined by results obtained
by studying the role of OX40 (Humphreys et al., 2007b). The
decreased CD4 T cell response in OX40-deficient MCMV-infected
animals is believed to be responsible for the observed slight
decrease in the inflationary CD8 T cell response at later stages
of infection. Interestingly, during MCMV infection, exogenous
treatment with anti-OX40 dramatically increased the CD4 T cell
response as well as the virus-specific CD8 T cell response. How-
ever, MCMV-specific CD8 T cell responses were not influenced by
OX40 treatment in MHCII−/− mice, indicating that the increase
of virus-specific CD4 T cells led to the increase in MCMV-specific
CD8 T cells.
The available studies indicate a role for CD4 T cell-mediated
supply of IL-2 to sustain CD8 T cell responses during the early
or latent phase of herpesvirus infection (Jennings et al., 1991;
Rajasagi et al., 2009; Walton et al., 2011b), or enhanced antigen
presenting cells (APC) co-stimulatory functions for instance via
CD40-CD40L (Sarawar et al., 2001), or OX-40-OX40L interactions
(Humphreys et al., 2007b).
In HSV infection CD4 T cells enable CD8 T cells to immigrate
into the infected tissue of the vaginal epithelium in an IFNγdepen-
dent manner (Nakanishi et al., 2009). Recently, CD4 T cell support
of CD8 T cell priming during early HSV-2 infection has been
reported where CD4 T cells promoted the entry of naive polyclonal
CD8 T cells to draining lymph nodes (Kumamoto et al., 2011), thus
enhancing the priming of virus-specific CD8 T cells. Although
MHV-68-specific CD8 T cell responses develop independently of
CD4 T cell help (Belz et al., 2003), lack of CD4 T cells resulted in
an increase of suppressive CD8 T cells which impaired MHV-68
control in an IL-10 dependent manner (Molloy et al., 2011). Fur-
thermore, in the absence of MHC class II expression the inhibitory
receptor PD-1 was significantly increased on CD8 T cells, resulting
in higher viral titers in the lungs of MHV-68 infected mice (Dias
et al., 2010). Interestingly, agonistic anti-CD40 treatment in CD4
T cell-deficient animals could rescue this phenotype.
CD4 T cells support humoral responses during latent persistent viral
infections
Murine CMV-infected mice deficient in CD4 T cells lack isotype-
switched and hence IgG antibodies directed against the virus
(Jonjic et al., 1989) (summarized in Table 2). However, antibodies
seem not to play an important role to control MCMV replication,
as their absence did not impair control of lytic viral replication
(Lawson et al., 1988; Jonjic et al., 1994). Nonetheless, MCMV-
specific antibodies are able to inhibit viral dissemination during
latency (Jonjic et al., 1994; Polic et al., 1998) and adoptive trans-
fer of memory B cells into T and B cell-deficient RAG-1−/− hosts
conferred protection (Klenovsek et al., 2007). Further, in a more
recent study, Wirtz et al. (2008) demonstrated that in addition to
inhibit viral spread from the entry port, MCMV-specific antibod-
ies are also able to locally inhibit dissemination at the site of viral
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replication. Administration of HCMV-specific antibodies to treat
renal transplant patients with primary or reactivating infection
was beneficial but this was not the case for all allogenic transplant
patients (Snydman et al., 1987; Guglielmo et al., 1994; Messori
et al., 1994; Munoz et al., 2001). Further, antibodies protect the
fetus during pregnancy and premature infants in humans and in
guinea pig models (Yeager et al., 1981; Fowler et al., 1992; Harri-
son et al., 1995). Evidence that CD4 T cells control at least partially
MCMV replication via provision of B cell help come from studies
of MHCII−/− and CD4−/− mice (Walton et al., 2011a). In con-
trast to MHCII−/−mice, not only lacking CD4 T cells but also IgG
antibodies, CD4−/− mice, a mouse strain that is able to support
immunoglobulin class switching, were able to eventually control
MCMV replication in the salivary gland approximately 6 months
post infection. This strongly indicates that CD4 T cells help B cells
to produce neutralizing antibodies which seem to play a marginal
role during the acute phase of infection but instead seem to be
able to control MCMV replication during late stages of infection.
Similarly, in MHV-68 infected mice, antibodies help to reduce
dissemination of virus undergoing recrudescence from latency
(Gangappa et al., 2002; Kim et al., 2002) and passive antibody
transfer can reduce lytic viral replication (Wright et al., 2009).
The influence of antibodies during HSV-2 infection is more
controversial but several studies indicate that B cell-mediated
immunity through antibodies is able to reduce viral replication
and to reduce HSV-2 related disease (Chan et al., 2011).
DIFFERENTIATION OF CD4 T CELLS DURING LATENT PERSISTENT VIRAL
INFECTIONS
Generation of virus-specific CD4 T cell responses requires the dif-
ferentiation of naive CD4 T cells into potent antiviral effector cells.
Recognition of viral antigens via pathogen-recognition receptors
induces a signaling cascade that activates APC and induces their
migration to the draining lymph nodes, where the priming of naive
CD4 T cells occurs. CD4 TCR recognition of viral antigens pre-
sented on MHC class II molecules expressed on activated APCs,
provision of APC-derived co-stimulatory signals, and the presence
of a specific cytokine milieu induce activation, proliferation, and
maturation of virus-specific CD4 T cells. Polarization of virus-
specific CD4 T cells toward specific CD4 T cell effector subtypes
depends on specific cytokine signaling inducing the activation of
distinct CD4 T cell transcription factors (Swain et al., 2012), on
the duration of antigen exposure (Constant and Bottomly, 1997),
and on the antigen presentation capacity of certain APC subsets
(Iwasaki and Medzhitov, 2010).
CD4 T cells with specificity for viruses being able to estab-
lish latency are mainly IFNγ, TNF, and IL-2 producing Th1 cells
(Milligan and Bernstein, 1995; Munz et al., 2000; Walton et al.,
2008). Differentiation of naive CD4 T cells into Th1 cells in general
requires the presence of the inflammatory cytokines IL-12, type I
IFN, and IFNγ (Constant and Bottomly, 1997). However, the spe-
cific role of these cytokines in priming of virus-specific CD4 T
cell responses during herpes viral infections is not entirely identi-
fied. VZV-specific Th1 polarization was shown to be dependent
on type I IFN and independent of IL-12 induction (Yu et al.,
2005). In contrast, the administration of IL-12 was shown to
enhance Th1 mediated antiviral responses toward HSV and EBV
(Sin et al., 1999; Popescu et al., 2003). Our own results suggest
that the priming of MCMV-specific CD4 T cells may be depen-
dent on IL-12 induction, since the neutralization of IL-12 led
to decreased MCMV-specific CD4 T cell responses (Mandaric
et al., 2012). In addition, we identified that presence of the anti-
inflammatory cytokine IL-10, secreted by APCs and other cells
during the early phase of mouse CMV infection (Mandaric et al.,
2012), leads to suppression of CD4 T cell priming. Thus, it seems
that a critical balance of virally induced cytokine signals deter-
mines the extent of virus-specific CD4 T cell priming and the
strength of induction of antiviral immune response. In addition
to the most prevalent Th1 CD4 T cells, IL-17-producing CD4 T
cells were reported during certain persistent viral infections, such
as HSV-2 and CMV (Arens et al., 2008; Suryawanshi et al., 2011),
although in significantly smaller numbers compared to Th1 cells,
indicating the heterogeneity of in vivo generated virus-specific
CD4 T cell responses. The precise role of Th17 cells in persistent
viral infections remains still elusive, especially in respect to their
antiviral function. Nevertheless, current reports suggest that Th17
cells contribute to virus-induced pathology during persistent viral
infections (Rajasagi et al., 2012).
Moreover, several studies addressed the role of co-stimulatory
signaling pathways for the induction of CD4 T cell responses dur-
ing herpes virus infections. The CD40-CD40L pathway was shown
to induce protective Th1 responses against HSV-2 in vivo (Sin
et al., 2001). Recently, the B7-CD28 pathway was reported to regu-
late the induction of MCMV-specific CD4 T cell responses (Arens
et al., 2011), whereas OX-40-OX40L pathway was shown to be
dispensable for the primary MCMV-specific CD4 T cell response,
but important to regulate the maintenance of CD4 T cell memory
responses (Humphreys et al., 2007b).
REGULATORY CD4 T CELLS IN LATENT PERSISTENT VIRAL INFECTIONS
CD4 T cells exerting immunosuppressive functions have been
reported during a number of persistent latent virus infections.
These cells regulate the extent of virally induced inflammation and
play a crucial role in prevention of virus-induced immunopathol-
ogy. The generation of an immunosuppressive environment, on
the other hand, facilitates virus-persistence and the deliberate
induction of anti-inflammatory responses is a prominent target
of immune evasion strategies employed by herpes viruses.
Foxp3+ T regulatory cells during latent persistent viral infections
CD25+ Foxp3 T regulatory cells (Tregs) play an important role
in regulation of immune tolerance but also in regulating antivi-
ral immune responses. Their prominent function is the sup-
pression of virus-specific CD8 T cell responses, either by cell-
to-cell-mediated interactions or via the production of the anti-
inflammatory cytokines IL-10 and TGF-β. Several reports imply
the importance of CD25+ FoxP3+ Tregs in herpes virus infec-
tions, especially in suppressing inflammatory responses at mucosal
peripheral tissues. In HSV-1 infection, Tregs were found at inflam-
matory sites of HSV infected ganglia and corneal stromal lesions in
HSV-induced stromal keratitis (Veiga-Parga et al., 2012), serving
to prevent tissue damage and attenuating the extent of inflamma-
tion (Belkaid and Rouse, 2005). On the other hand, Tregs delay
the antiviral immune response toward herpes viral infections and
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may promote viral persistence (Suvas et al., 2003). Furthermore,
the presence of CD4+ CD25+ cells was shown to suppress the
function of antiviral CD8 T cells upon HCMV infection in vitro in
an antigen-independent manner (Aandahl et al., 2004). Another
study reported in vitro a role of Treg secreted TGF-β for suppres-
sion of MCMV-specific T cell responses (Li et al., 2010). Taken
together, although the precise mechanisms of CD25+ Foxp3 Tregs
function still remain to be identified for many herpes virus infec-
tions, these cells represent an important regulatory subtype that
strongly impacts the virus/host balance during persistent virus
infections.
IL-10-producing CD4 T regulatory cells
One potent mechanism of CD4 T cell exerted regulatory func-
tions is the secretion of the immunosuppressive cytokine IL-10.
Development of virus-specific CD4 T cells producing IL-10 has
been reported for numerous herpes virus infections, such as VZV
(Vukmanovic-Stejic et al., 2013), HSV (Ramakrishna et al., 2011),
CMV (Humphreys et al., 2007a), and EBV (Marshall et al., 2003)
infections. The secretion of IL-10 has been detected in different
subsets of CD4 T cells, including FoxP3+ CD4 cells (Wingate
et al., 2009; Vukmanovic-Stejic et al., 2013) or FoxP3− CD4 cells
(Marshall et al., 2003; Ramakrishna et al., 2011).
CD4 T cell-derived IL-10 is in general proposed to serve
as an inhibitory mechanism to regulate the function of other
immune cells, such as macrophages and APCs or IFNγ-producing
CD4 T cells (Saraiva and O’Garra, 2010) and thus to suppress
immunopathology inferred by activated immune cells. Recently,
in an HSV-induced encephalitis model, IL-10 production by
FoxP3−ICOS+ CD4 T cells was shown to suppress the pathogenic
function of inflammatory macrophages in the brain (Ramakrishna
et al., 2011). Moreover, the recovery from EBV-induced infectious
mononucleosis has been correlated with the appearance of IL-10-
secreting virus-specific CD4 T cells (Marshall et al., 2007). These
CD4 T cells were specific for the latent EBV antigen LMP-1 and
were shown to inhibit IFNγ secretion of CD4 T cells of other EBV
antigen specificities. Furthermore, during the persistent phase of
MCMV infection, IL-10-producing FoxP3− CD4 T cells have been
detected selectively in salivary gland mucosal tissue, which is a
major site of mouse CMV persistence and hence an important
organ for horizontal virus transmission (Humphreys et al., 2007a).
Interestingly, the activation of CD40-CD40L pathway altered the
ratio of IFNγ- to IL-10- secreting CD4 T cells in this mucosal
tissue, suggesting that IL-10 may act to suppress the downstream
effects of co-stimulatory-mediated signaling pathways.
VIRAL ESCAPE FROM CD4 T CELLS
Regarding the pivotal role of CD4 T cells, herpes viruses encode
an armor of different proteins to manipulate CD4 T cell responses
(reviewed by Wiertz et al., 2007; Abendroth et al., 2010; Zuo and
Rowe, 2012). Immune evasins target several aspects of CD4 T
cell maturation and function (Powers et al., 2008; Mason et al.,
2012), impair DC functions by down-regulating co-stimulatory
molecules (Rolle and Olweus, 2009), by interfering with the IFN
responses (Marshall and Geballe,2009),by manipulating the NFκB
pathway, by modulating expression of MHC class II (Wiertz et al.,
2007) as well as co-stimulatory molecules (Loewendorf et al., 2004;
Mintern et al., 2006), and even by encoding their own inhibitory
receptors (Cheung et al., 2005). The MHC class II presentation
pathway is targeted at several points (Wiertz et al., 2007; Aben-
droth et al., 2010; Zuo and Rowe, 2012): herpes virus proteins were
shown to suppress the CIITA promoter, thereby inhibiting MHC
class II transcription, to degrade mRNA, to target the folded MHC
class II protein for degradation, and to manipulate the invari-
ant chain of the MHC class II molecules, thereby interfering with
proper loading and presentation of CD4 T cell epitopes. On the
cell surface they can divert the MHC class II molecules to exosomes
and manipulate their recognition by the T cell receptor (Ressing
et al., 2003). A comprehensive review of mechanisms exploited by
herpes viruses to evade recognition by CD4 T cells is far beyond the
scope of this review but the vast abundance of proteins encoded by
these viruses to evade this lymphocyte subset further underlines
their importance and effectiveness for viral control.
Apart from encoding immune evasins, chronic viral infections
induce an immunosuppressive environment, thereby promoting
virus-persistence. A recent study in an experimental model of
HCMV latency revealed that the secretome of latently infected
cells is enriched in immunosuppressive cytokines such as IL-10 and
TGF-β that inhibit CD4 T cell cytokine secretion and MHC class
II-mediated CD4 T cell cytotoxicity, highlighting a new mode of
evasion from CD4 T cell responses during HCMV latency (Mason
et al., 2012). We have recently shown that early induction of cel-
lular IL-10 during acute mouse CMV infection leads to impaired
NK/DC cross-talk and suppression of CD4 T cell priming affect-
ing CD4 T cell proliferation and cytokine secretion, thus shifting
the virus/host balance and promoting virus-persistence (Mandaric
et al., 2012).
Intriguingly, in spite of the large number of immune-regulatory
functions of herpes viruses, a robust CD4 as well as CD8 T cell
response can be elicited in the host and contributes to protection.
One possible explanation is that viral antigens are not directly pre-
sented by infected cells but rather by bystander cells such as APCs.
These cells may process and present viral antigens to T cells after
taking up viral proteins, defective viral particles, or apoptotic bod-
ies from CMV-infected cells without being necessarily infected
themselves. As presentation of exogenous antigens to CD8 but
not CD4 T cells requires cross-presentation, a function specifically
confined to particular DC subsets, CD4 T cells may have advan-
tages to respond to herpes virus infections especially in organs
devoid of cross-presenting APCs. Consistent with this hypothesis,
we recently could demonstrate in MCMV-infected hosts that sali-
vary gland-resident APCs lack mechanisms to present exogenous
antigens to CD8 T cells, which likely contributes to the dependence
on CD4 T cells to control lytic MCMV replication in this organ
(Walton et al., 2011a).
CD4 T CELL RESPONSES DURING ACTIVE CHRONIC VIRAL
INFECTIONS
INTRODUCTION
A major challenge which actively replicating chronic infections
impose on host immunity is the continued encounter of high
levels of viral antigens by adaptive immune cells, which requires
that immune cell numbers and their function ought to be reg-
ulated to afford a certain level of virus control while avoiding
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detrimental immunopathology. Furthermore, rapid evolution and
immune-mediated antigen escape variant selection in case of per-
sistently infecting viruses with high mutation potential present a
continuously evolving spectrum of new antigenic determinants to
the host’s immune system. A complex regulatory network adjusts
the size and the function of adaptive immune responses during
actively replicating chronic infections. This regulation is partic-
ularly well understood for CD8 T cell responses which bear the
potential to cause major immunopathological insult via direct
cytotoxicity and proinflammatory cytokine production (Frebel
et al., 2010; Wherry, 2011). Considerably less is currently known
about the regulation and differentiation of CD4 T cell responses
during active chronic viral infections. In this part of the review
we will summarize current knowledge on this topic, focusing on
the role of CD4 T cells and the differentiation and maintenance
of CD4 T cells during active chronic viral infections, on the role
of Tregs and means of manipulating CD4 T cell responses during
active chronic viral infections (Figure 1B). We will concentrate
on insights from the murine chronic lymphocytic choriomenin-
gitis virus (LCMV) and Friend virus (FV) infection models and
complement those with observations made in humans chronically
infected with HIV-1 and Hepatitis C virus (HCV).
ROLE OF CD4 T CELLS IN ACTIVE CHRONIC VIRAL INFECTIONS
CD4 T cells promoting control of chronic viral infections
Observations from a number of experimental or natural chronic
active viral infections in mice and humans indicate that presence
of CD4 T cells and in particular of functional virus-specific CD4
T cells is involved in control of the chronic infection. In human
HIV-1 infection robust HIV-1-specific CD4 T cell responses, mea-
sured by their proliferative capacity, their functional avidity, their
cytokine secretion potential, and their frequencies, are associated
with low HIV-1 plasma viral loads (reviewed in Porichis and Kauf-
mann, 2011). Conversely, vigorous and functional CD4 T cell
responses during the early phases of HCV infection correlate with
subsequent control of the infection (reviewed in Klenerman and
Thimme, 2012). More direct evidence for the importance of CD4 T
cells responses in the control of chronic viral infections is available
from the mouse experimental infection models of LCMV and FV.
LCMV infection. Infection of immune-competent mice with
high doses of specific LCMV strains (i.e., LCMV Clone 13 and
LCMV Docile) leads to protracted control of the infection and
thereby results in a prolonged phase of active viral replication
which lasts between 2 and 4 months for Clone 13 and Docile,
respectively (Althage et al., 1992). This infection model has proven
to be very useful to study the consequences of prolonged exposure
of adaptive immunity to high levels of viral antigens and conversely
has been used to elaborate interventions which allow altering the
virus host balance in favor of virus control (reviewed in Klener-
man and Hill, 2005; Frebel et al., 2010; Wherry, 2011). A number of
seminal observations were first made in this experimental model
which were later confirmed and extended to persistent human
viral infections (Pircher et al., 1990; Seiler et al., 1999; Hangartner
et al., 2006b; Frebel et al., 2010; Wherry, 2011). Most importantly,
physical and functional down-regulation of virus-specific CD8 T
cell responses (T cell exhaustion) was first described in LCMV
infection (Moskophidis et al., 1993) and has since been a matter
of intense investigation. A number of molecular pathways con-
tributing to T cell exhaustion were identified over the past years
(Frebel et al., 2010; Wherry, 2011) and this knowledge is currently
used to develop interventions with the aim of restoring CD8 T cell
numbers and function in the setting of chronic viral infections or
in cancer therapies (Blank and Mackensen, 2007; Topalian et al.,
2012).
Numerous reports indicated exacerbation of chronic LCMV
infections in the absence of CD4 T cells (Battegay et al., 1994; Alt-
feld and Rosenberg, 2000; Wiesel and Oxenius, 2012), preventing
eventual control of infection (Matloubian et al., 1994; Ou et al.,
2001; Fuller and Zajac, 2003; Wherry et al., 2003a). Such exac-
erbation was associated with progressive functional deterioration
and deletion of LCMV-specific CD8 T cell responses (Matloubian
et al., 1994; Zajac et al., 1998; Kristensen et al., 2002; Fuller et al.,
2004). However it is largely unclear from these studies whether
there is a direct contribution of CD4 T cells to promote control
of chronic LCMV infection or whether CD4 T cells contribute
to viral control indirectly via support of CD8 T cell responses
or via support of humoral immunity. The majority of studies
addressing this issue used adoptive immunotherapy interventions
and point toward an indirect role of CD4 T cells in supporting
LCMV control. LCMV-specific CD4, CD8, or B cells were adop-
tively transferred into chronically infected hosts and their ability
to reduce viral loads was assessed. Adoptive immunotherapy stud-
ies performed in LCMV carrier mice (i.e., mice infected either
at birth or in utero with LCMV which exhibit T cell tolerance
toward LCMV) indicated a role for CD4 T cells, B cells, and IFNγ
signaling for the control of LCMV infection (Planz et al., 1997)
and transfer of memory T cells purged LCMV infection in carrier
mice (Lauterbach et al., 2006; Garidou et al., 2009). Also, func-
tional exhaustion of LCMV-specific CD8 T cells during adoptive
immunotherapy in LCMV carrier mice can be prevented by co-
transfer of antiviral CD4 T cells and B cells which led to reduction
of viral loads, thereby lowering the antigen levels and facilitat-
ing the maintenance of functional CD8 T cells (Hunziker et al.,
2002a). Finally, indirect evidence for direct or indirect antivi-
ral activity of LCMV-specific CD4 T cells originates from the
observation that transfer of LCMV-specific CD4 T cells into per-
sistently infected mice can select for LCMV escape mutants that
bear alterations in the targeted LCMV-derived CD4 T cell epitope
(Ciurea et al., 2001b). A recent report also indicated that adoptive
transfer of LCMV-specific CD4 T cells re-invigorated functional
competence of LCMV-specific CD8 T cells (i.e., proliferation and
cytokine production) in chronically infected mice, which was fur-
ther augmented by concomitant PD-L1 blockade (Aubert et al.,
2011).
The mechanisms by which T helper cells promote CD8 T cell
responses are only beginning to be understood and very little
is currently known about their role in sustaining virus-specific
humoral immunity (Fahey et al., 2011; Harker et al., 2011). Over-
all, there is limited knowledge about the role, regulation, and
evolution of antibody responses during chronic viral infections.
However as antibodies bear less immunopathological potential
compared to cytotoxic T cells, emphasizing humoral immunity
with concomitant down-regulation of antiviral T cell responses
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might represent an important strategy of how the host protects
itself against harmful immunopathology.
Two cytokines, namely IL-2 and IL-21, are critical for the mech-
anism by which CD4 T cells support CD8 T cell responses during
chronic LCMV infection (Bachmann et al., 2007; Elsaesser et al.,
2009; Frohlich et al., 2009; Yi et al., 2009; Walton et al., 2011b).
In contrast to acute/resolved infections where memory CD8 T cell
maintenance is antigen-independent but dependent on the home-
ostatic cytokines IL-7 and IL-15 (Schluns et al., 2000; Wherry and
Ahmed, 2004; Surh and Sprent, 2008), maintenance of CD8 T
cells during actively replicating chronic infections is strictly depen-
dent on antigen and increased cell turnover (Wherry et al., 2003b;
Agnellini et al., 2007). An ability which seems to be supported by
T helper cells and in particular by IL-21 secreted by CD4 T cells
in the context of chronic antigen encounter (Elsaesser et al., 2009;
Frohlich et al., 2009; Yi et al., 2009; Iannello et al., 2010; Yue et al.,
2010). These initial studies in LCMV infection were later extended
to HIV infection and IL-21-producing CD4 T cells were asso-
ciated with improved control of HIV-1 infection and preserved
CD8 T cell function in humans (Iannello et al., 2010; Yue et al.,
2010; Chevalier et al., 2011; Williams et al., 2011). While these
findings support a direct role for IL-2/IL-21 signaling on CD8
T cell maintenance during chronic LCMV infection, they do not
exclude a concomitant role of these IL-21-producing CD4 T cells
for humoral immunity as IL-21 is a hallmark cytokine of follicular
T helper cells (TFH), as discussed later in Section “Differentiation
of CD4 T Cells During Active Chronic Viral Infections.”
Friend virus infection. Friend virus is a retroviral complex
of Friend murine leukemia virus (F-MuLV) and spleen focus-
forming virus (SFFV) and leads to persistent infection of mice
(Hasenkrug and Chesebro, 1997). A recent review discusses var-
ious facets of CD4 T cell immunity during FV infection (Nair
et al., 2011). Specifically, FV-specific CD4 T cells were shown to
mediate direct antiviral effects leading to reduced viral replication
and reduced spread of FV to the erythroid lineage as well as to
reduced induction of erythroleukemia (Hasenkrug et al., 1998).
CD4 T cells specific for the FV envelope protein provide substan-
tial protection against FV-induced disease in the absence of CD8 T
cells and antibody responses (Pike et al., 2009). The mechanisms
by which FV-specific CD4 T cells afford control of FV infections
relies on their ability to produce IFNγ. This cytokine exerts a direct
suppressive effect on viral replication and augments CD4 T cell-
mediated cytolytic activity (Iwashiro et al., 2001b). Consistent with
a protective role of CD4 T cells, their in vivo depletion during acute
infection promoted viral spread as well as onset of erythroleukemia
and resulted in reduced maintenance of FV-specific CD8 T cells as
well as neutralizing antibody responses (Nair et al., 2010).
CD4 T cell-mediated pathology during chronic viral infections
Besides contributing to direct or indirect control of active chronic
viral infections, virus-specific CD4 T cell responses also bear the
potential of causing immunopathology, particularly in case of
(abnormally) increased frequencies or in case of defective immune
regulation.
LCMV infection. The presence of large numbers of LCMV-
specific CD4 T cells in the setting of a chronic infection predispose
to CD4 T cell-mediated immunopathology. When transgenic mice
expressing a TCR specific for the immunodominant LCMV CD4
T cell epitope are infected with high doses of LCMV, they succumb
to TNF-mediated cachexia and immunopathology (Oxenius et al.,
1998; Hunziker et al., 2002b). In beta-2 microglobulin deficient
mice CD4 T cells are responsible for a chronic wasting syn-
drome (Doherty et al., 1993) and also in immune-competent mice
contribute to morbidity (Stamm et al., 2012). Further, vaccina-
tion can exacerbate CD4 T cell-mediated pathology: when beta-2
microglobulin deficient mice are infected with LCMV they exhib-
ited CD4 T cell-mediated immunopathology in the brain which
was augmented by previous immunization with recombinant Vac-
cinia virus, and the severity of immunopathology correlated with
the number of IFNγ-producing CD4 T cells (Hildeman et al.,
1997). Furthermore, CD4 T cells were shown to contribute to the
destruction of the splenic architecture following LCMV infection
by a CD4 T cell derived TNF and IFNγ-dependent mechanism,
leading to subsequent immunodeficiency (Matter et al., 2006).
Friend virus infection. During FV infection CD4 T cells medi-
ate immunopathology as evidenced by bone marrow pathology,
anemia, and weight loss via local IFNγ production by FV-specific
CD4 T cells (Antunes et al., 2008). FV-specific CD4 T cells and
their capacity to precipitate immunopathology was found to be
regulated by B cells, as antigen presentation by B cells protected
from CD4 T cell-mediated immunopathology by shifting the bal-
ance toward TFH generation at the expense of Th1 differentiation
(Ploquin et al., 2011).
DIFFERENTIATION OF CD4 T CELLS DURING ACTIVE CHRONIC VIRAL
INFECTIONS
Viral infections are generally associated with the differentiation
of IFNγ-, TNFα-, and IL-2-producing Th1 cells, driven by Type
I IFN, IL-12, and IFNγ production provided by innate immune
cells during viral infections. This fate determination, provided by
inflammatory cytokines (also referred to as signal 3), is initiated
by the respective cytokine receptors and the downstream signaling
transducer and activator of transcription (STAT) proteins which
lead to the induction of master transcription factors (T-bet and
eomesodermin in case of Th1 cells). While fate determination of
CD4 T cells has been extensively studied in case of acute infections
(reviewed in Zhu et al., 2010), the following section will specifically
focus on the differentiation of CD4 T cells during active chronic
viral infections.
Lymphocytic choriomeningitis virus
Akin LCMV-specific CD8 T cell responses (Frebel et al., 2010;
Wherry, 2011) it was initially suggested that virus-specific CD4 T
helper cells may also be exhausted during chronic LCMV infec-
tion (Oxenius et al., 1998; Fuller and Zajac, 2003; Fuller et al.,
2004; Brooks et al., 2005), exemplified by a progressive loss of
Th1-related cytokine production (IL-2, TNFα, and IFNγ). Not
only recently primed LCMV-specific CD4 T cells are functionally
down-regulated during chronic LCMV infection, but also pre-
established vaccine-induced LCMV-specific and bystander CD4 T
cell responses (Mothe et al., 2007). In a mouse model of dosed
exposure of CD4 T cells to cognate antigen by inducible anti-
gen expression in DCs, impaired JUN phosphorylation upon TCR
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stimulation was found in CD4 T cells which had been exposed
for prolonged periods to high levels of antigen (Han et al., 2010).
Antigen removal led to partial restoration of function (prolifer-
ation) but only to some extent to restoration of IL-2 and TNF
production.
Transcriptional profiling of LCMV-specific CD4 T cells isolated
from chronically infected mice indicated analogies in the tran-
scriptional regulation of CD4 and CD8 T cell down-regulation
during persistent infection. Several genes coding for inhibitory
receptors and transcription factors which are involved in the func-
tional down-regulation of virus-specific CD8 T cells were similarly
regulated in the CD4 T cell counterpart (Pdcd1/PD-1, Lag3/LAG3,
Cd244/2B4, Tnfrsf9/4-1BB, Batf/BATF, Prdm1/Blimp-1) (Wherry
et al., 2007; Shin et al., 2009; Quigley et al., 2010).
Also in case of HIV-1 infection molecules of the B7 family
are found to participate in CD4 T cell regulation, in particular
PD-1, CTLA-4, and Tim-3 (reviewed in Kaufmann and Walker,
2009; Simone et al., 2009; Porichis and Kaufmann, 2012). A large
fraction of HIV-specific CD4 T cells were found to co-express mul-
tiple inhibitory receptors, including PD-1, CTLA-4, TIM-3, and
co-expression of these receptors correlated with increased plasma
viral load and in vitro blockade of PD-1 promoted HIV-specific
CD4 T cell proliferation (Day et al., 2006; Kassu et al., 2010). Also
in chronic HCV infection, HCV-specific CD4 T cells express PD-1
(Kasprowicz et al., 2008) and CTLA-4 and blockade of PD-1, IL-
10, and TGF-β is efficient in restoring in vitro proliferation and
cytokine production of HCV-specific CD4 T cells (Raziorrouh
et al., 2011).
Recent work, however, showed that LCMV-specific T helper
cells seem to preferentially differentiate into TFH during chronic
LCMV infection, likely providing continuing support for virus-
specific humoral immunity and eventual control of the infection
(Fahey et al., 2011; Harker et al., 2011). Concomitant to the reduc-
tion in virus load, CD8 T cell responses were improved with respect
to numbers and function (Fahey et al., 2011). Also during chronic
LCMV infection, IL-6 has recently been identified to be the key
molecule acting on CD4 T cells during late stages of chronic infec-
tion (Harker et al., 2011). Signals via the IL-6 receptor on CD4 T
cells drove their differentiation into TFH cells in a Bcl-6 dependent
manner. Increased numbers of TFH cells were essential for ger-
minal center formation, LCMV-specific antibody production, and
subsequent viral control. However, the capacity of LCMV-specific
CD4 T cells to support LCMV-specific humoral immunity during
established chronic infection does seem to have its limits, as they
fail to support the generation of antibody responses specific for
emerging escape variants (Ciurea et al., 2001a).
Prolonged TCR stimulation in the context of chronic LCMV
infection seems to facilitate TFH generation, which is independent
of B cells (Fahey et al., 2011). This is consistent with a previous
study showing that prolonged CD4 T cell activation favors TFH
differentiation independently of B cells (Deenick et al., 2010) but
in contrast to situations with much lower amounts of CD4 T cell
stimulating antigens where B cells are required for the differen-
tiation of TFH cells (Johnston et al., 2009; Cannons et al., 2010).
In accordance to chronic LCMV infection expansions of TFH with
HIV-1 specificity were reported in case of human HIV-1 infection
(Lindqvist et al., 2012).
These observations reinforce a lot of interest in the role of anti-
body responses during chronic infections. Antibodies can critically
contribute to reduce systemic viral spread by limiting infectious
particles via their neutralization or opsonization (Burton, 2002;
Bachmann et al., 2004; Hangartner et al., 2006a,b; Bergthaler et al.,
2009). To date it is unclear whether and how B cells need to be con-
tinuously supported by TFH cells during chronic infection. This
deviation from a typical proinflammatory Th1 response to a B cell
helper response might be a means by which the host tries to reach
an optimal equilibrium between virus control and avoidance of
immunopathology. That such emphasis on TFH cell differentiation
during viral chronicity is linked to optimizing antibody responses,
is a very attractive hypothesis and demands further investigations.
Friend virus
In the case of FV infection the functional capacities of FV-specific
CD4 T cells seem to be affected by exposure to high levels of
antigen. FV-specific CD4 T cells were found to produce IFNγ
and to contribute to reduction of viral loads up to 2 weeks post
transfer into FV infected mice, but thereafter lost their antiviral
activity (Nair et al., 2010). Comparable to LCMV infection (Fahey
et al., 2011), FV infection also induces Th1 and TFH differentiation
but as opposed to chronic LCMV infection TFH differentiation is
promoted by B cells (Ploquin et al., 2011), perhaps due to lower
antigen amounts perceived by FV-specific CD4 T cells compared
to LCMV-specific CD4 T cells.
Tregs AND CHRONIC VIRAL INFECTIONS
A CD4 T cell subset which is involved in immune regulation in the
context of chronic antigen exposure is the Treg subset. Induced or
increased numbers of Tregs as observed during chronic infections
leads to suppression of effector CD8 T cell responses (Belkaid and
Rouse, 2005; Punkosdy et al., 2011). In response to chronic LCMV
infection marked and sustained expansion of Tregs is observed
which is driven by infection-induced expression of a retroviral
superantigen encoded in the mouse genome (Punkosdy et al.,
2011). So far there is limited knowledge on how these increased
numbers of Tregs impinge on LCMV-specific adaptive immunity.
Besides Tregs additional cell types were shown to regulate the size
of the antiviral CD4 T cell response in the setting of a chronic
LCMV infection. These include NK cells which were shown to kill
activated virus-specific CD4 T cells and therefore to reduce the
overall size of the antiviral CD4 T cell pool (Waggoner et al., 2012)
and IL-10-producing DCs or T cells which downregulate LCMV-
specific CD4 T cell responses (Brooks et al., 2006, 2010; Ejrnaes
et al., 2006).
In the FV infection model,Tregs develop during the second week
of infection and suppress CD8 T cell functions which is associated
with impaired virus control (Zelinskyy et al., 2006, 2009). Treg fre-
quencies double in size in response to FV infection compared to
naïve mice and these cells remain immunosuppressive also after
adoptive transfer into new hosts (Iwashiro et al., 2001a). Tregs from
FV infected mice suppress in vitro effector cell differentiation of
naïve CD8 T cells via direct cell-cell contact and irrespective of
TCR specificity of the CD8 T cells. Further, they also suppress
the function of in vivo activated effector CD8 T cells (Robertson
et al., 2006). Transient depletion of Tregs is sufficient to reinvigorate
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virus-specific CD8 T cell responses, thereby decreasing virus load
(Dietze et al., 2011) and also ameliorating the antiviral activity of
FV-specific CD4 T cells (Nair et al., 2010).
In human HIV infection a majority of studies also report
increased Treg frequencies which were proposed to contribute
to down-regulation of HIV-specific immunity but also to par-
ticipate in limiting overall immune activation and preventing
immunopathology (reviewed in Rouse et al., 2006; Moreno-
Fernandez et al., 2012). Also in chronic HCV and HBV infection
Tregs are implicated to modulate virus-specific immune responses,
thereby potentially promoting disease progression or preventing
infection triggered immunopathology (reviewed in Manigold and
Racanelli, 2007; Miroux et al., 2010).
Taken together, sustained expansions of Tregs are observed in
a number of chronic viral infections, sometimes accumulating at
the site of viral persistence. Two opposing roles can be attrib-
uted to these increased numbers of Tregs, on one hand they might
impair virus-specific immunity and thereby promote viral persis-
tence and on the other hand they might represent an important
means of the host to limit immunopathology during protracted
viral infections.
CONCLUDING REMARKS
A large body of studies investigating CD4 T cell differentia-
tion and function during latent and chronic viral infections has
revealed that these cells possess a remarkable number of differ-
ent functional facets. These range from direct antiviral protective
functions via production of cytokines or direct cytotoxic activ-
ity (mainly demonstrated for human herpes virus infections),
their long-term support of CD8 T cell and B cell responses,
their immune-regulatory function to their potential of causing
immunopathology.
Evidence for a direct antiviral function of CD4 T cells during
persistent viral infections comes from studies in CD4 T cell-
deficient or compromised hosts. A pivotal role of CD4 T cells
in effectively contributing to viral control is also supported by
the observation that herpes viruses have elaborated an impres-
sive number of immune evasion mechanisms which target the
CD4 T cell response and by the observation of viral mutational
escape from immunodominant CD4 T cell responses during active
chronic viral infections.
In the context of persistent viral infection a tight regula-
tion of T cell responses is essential as effector functions trig-
gered by the continued presence of antigen might bear severe
immunopathological potential. While we have seen over the
recent years an exciting progress in understanding the regula-
tion of virus-specific CD8 T cells in the setting of persistent
and chronic viral infections, much less is known about CD4 T
cells. Recent data indicate that CD4 T cells are not functionally
down-regulated akin their CD8 T cell counterpart in the setting
of chronic viral infection but rather deviate their differentiation
toward the TFH subset, thereby likely avoiding immunopathol-
ogy and at the same time supporting humoral immunity. Thus,
our understanding of the regulation and function of CD4 T
cells during persistent viral infections definitively needs to be
advanced to understand immune control of persistent infec-
tions and eventually to harness this population of cells for vac-
cine or interventional purposes in the context of persistent viral
infections.
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